Literature DB >> 286549

Iris involvement in granulocytic sarcoma.

H D Perry, F J Mallen.   

Abstract

A 6-year-old boy with a diagnosis of acute myeoblastic leukemia in remission developed iris infiltration accompanied by uveitis, hypopyon, and vitreous hemorrhage, which was initially unilateral, later becoming bilateral. Pathologically, the eyes showed leukemic infiltrates in the conjunctiva, episclera, sclera, ciliary body, trabecular meshwork, canal of Schlemm, choroid, vitreous, and the iris. Leder stain studies showed positive esterase activity, indicating granulocytic sarcoma. Granulocytic sarcoma may appear intraocularly as iris nodules. These iris nodules may be the initial manifestation of granulocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 286549     DOI: 10.1016/0002-9394(79)90243-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Childhood leukaemia: relapse in the anterior segment of the eye.

Authors:  P Novakovic; S J Kellie; D Taylor
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

2.  Orbital granulocytic sarcoma.

Authors:  F A Stockl; A M Dolmetsch; M A Saornil; R L Font; M N Burnier
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

3.  Metastatic carcinoma of the iris simulating iridocyclitis.

Authors:  J J Woog; J Chess; D M Albert; D K Dueker; F G Berson; J Craft
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

Review 4.  Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives.

Authors:  Nasrine Anais El Salloukh; Dany G Hage; Anna Z Bashshur; Wajiha Jurdi Kheir
Journal:  Clin Ophthalmol       Date:  2022-07-01

5.  Bilateral orbital myeloid sarcoma as initial manifestation of acute myeloid leukemia.

Authors:  Kamel Hmidi; Sonia Zaouali; Riadh Messaoud; Bahri Mahjoub; Wafa Ammari; Leila Bacha; Adnene Laatiri; Salah Jenzeri; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2007-05-24       Impact factor: 2.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.